David E. Nichols - Publications, H-index & Citations

David E. Nichols

Purdue University System

61H指数

565论文数

1.6W被引数

收录论文 70

发表时间

Chemistry/structural biology of psychedelic drugs and their receptor(s)迷幻药及其受体的化学/结构生物学

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2024-10-02

PREAI

Gumpper, Ryan H.; Nichols, David E.

Remove barriers to clinical research for schedule 1 drugs with therapeutic potential

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2023-05-02

OAAI

King, Leslie; Nutt, David; Nichols, David

Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD

NEURON

IF15

2022-10-01

OAAI

Cao, Can; Barros-Alvarez, Ximena; Zhang, Shicheng; Kim, Kuglae; Damgen, Marc A.; Panova, Ouliana; Suomivuori, Carl-Mikael; Fay, Jonathan F.; Zhong, Xiaofang; Krumm, Brian E.; Gumpper, Ryan H.; Seven, Alpay B.; Robertson, Michael J.; Krogan, Nevan J.; Huttenhain, Ruth; Nichols, David E.; Dror, Ron O.; Skiniotis, Georgios; Roth, Bryan L.

Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated

FRONTIERS IN PSYCHIATRY

IF3.2

2022-03-25

OAAI

Nichols, David E.

The History of Psychedelics in Psychiatry

PHARMACOPSYCHIATRY

IF2.2

2020-12-07

OAAI

Nichols, David E.; Walter, Hannes

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) (vol 236, pg 799, 2019)

PSYCHOPHARMACOLOGY

IF3.3

2018-11-15

OAAI

Halberstadt, Adam L.; Klein, Landon M.; Chatha, Muhammad; Valenzuela, Laura B.; Stratford, Alexander; Wallach, Jason; Nichols, David E.; Brandt, Simon D.

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

PSYCHOPHARMACOLOGY

IF3.3

2018-10-08

OAAI

Halberstadt, Adam L.; Klein, Landon M.; Chatha, Muhammad; Valenzuela, Laura B.; Stratford, Alexander; Wallach, Jason; Nichols, David E.; Brandt, Simon D.

Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models

ACS CHEMICAL NEUROSCIENCE

IF3.9

2018-09-25

PREAI

Volgin, Andrey D.; Yakovlev, Oleg A.; Demin, Konstantin A.; Alekseeva, Polina A.; Kyzar, Evan J.; Collins, Christopher; Nichols, David E.; Kalueff, Allan V.

Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)化学神经科学中的黑暗经典: 麦角酸二乙酰胺 (LSD)

ACS CHEMICAL NEUROSCIENCE

IF3.9

2018-02-20

PREAI

Nichols, David E.

Psychedelic Drugs in Biomedicine

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2017-11-01

117

PREAI

Kyzar, Evan J.; Nichols, Charles D.; Gainetdinov, Raul R.; Nichols, David E.; Kalueff, Allan V.

Experimental evaluation of the generalized vibrational theory of G protein-coupled receptor activation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2017-05-12

OAAI

Hoehn, Ross D.; Nichols, David E.; McCorvy, John D.; Neven, Hartmut; Kais, Sabre

Neural correlates of the LSD experience revealed by multimodal neuroimaging 多模态神经影像学揭示的LSD经验的神经相关性

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2016-04-11

521

OAAI

Carhart-Harris, Robin L.; Muthukumaraswamy, Suresh; Roseman, Leor; Kaelen, Mendel; Droog, Wouter; Murphy, Kevin; Tagliazucchi, Enzo; Schenberg, Eduardo E.; Nest, Timothy; Orban, Csaba; Leech, Robert; Williams, Luke T.; Williams, Tim M.; Bolstridge, Mark; Sessa, Ben; McGonigle, John; Sereno, Martin I.; Nichols, David; Hellyer, Peter J.; Hobden, Peter; Evans, John; Singh, Krish D.; Wise, Richard G.; Curran, H. Valerie; Feilding, Amanda; Nutt, David J.

Psychedelics 迷幻剂

PHARMACOLOGICAL REVIEWS

IF17.3

2016-04-01

1.1K

OAAI

Nichols, David E.

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylarnine Analogues

ACS CHEMICAL NEUROSCIENCE

IF3.9

2015-01-21

OAAI

Nichols, David E.; Sassano, M. Flori; Halberstadt, Adam L.; Klein, Landon M.; Brandt, Simon D.; Elliott, Simon P.; Fiedler, Wolfgang J.

The G Protein-Biased κ-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2015-01-01

192

OAAI

White, Kate L.; Robinson, J. Elliott; Zhu, Hu; DiBerto, Jeffrey F.; Polepally, Prabhakar R.; Zjawiony, Jordan K.; Nichols, David E.; Malanga, C. J.; Roth, Bryan L.

New victims of current drug laws

NATURE REVIEWS NEUROSCIENCE

IF26.7

2013-10-23

OAAI

Nutt, David J.; King, Leslie A.; Nichols, David E.

Effects of Schedule I drug laws on neuroscience research and treatment innovation

NATURE REVIEWS NEUROSCIENCE

IF26.7

2013-06-12

238

PREAI

Nutt, David J.; King, Leslie A.; Nichols, David E.

Extensive Rigid Analogue Design Maps the Binding Conformation of Potent N-Benzylphenethylamine 5-HT2A Serotonin Receptor Agonist Ligands

ACS CHEMICAL NEUROSCIENCE

IF3.9

2012-08-01

OAAI

Juncosa, Jose I., Jr.; Hansen, Martin; Bonner, Lisa A.; Cueva, Juan Pablo; Maglathlin, Rebecca; McCorvy, John D.; Marona-Lewicka, Danuta; Lill, Markus A.; Nichols, David E.

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

PSYCHOPHARMACOLOGY

IF3.3

2012-01-06

OAAI

Halberstadt, Adam L.; Nichols, David E.; Geyer, Mark A.

Comparison of the D1 dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease 在帕金森氏病的6-OHDA大鼠模型中比较D1多巴胺完全激动剂，二氧嘧啶和多蒽碱

PSYCHOPHARMACOLOGY

IF3.3

2012-01-06

PREAI

McCorvy, John D.; Watts, Val J.; Nichols, David E.

研究方向